SCHEMBL10068581

SCHEMBL10068581

COC(=O)NCCO[C@@H](c1cccc(Cl)c1)c1cc(OC(F)F)cc(C(=O)OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
MEN1 O00255 5/20 0.38
MAPT P10636 5/20 0.38
KMT2A Q03164 5/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
HTT P42858 4/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GAA P10253 1/20 0.38
LMNA P02545 3/20 0.37
REN P00797 6/20 0.37
CYP3A4 P08684 2/20 0.37
NPSR1 Q6W5P4 4/20 0.37
RAB9A P51151 3/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068969 1.00 ADRB2 (0.39) ADRB2ADRB1ADRB3MEN1MAPT
SCHEMBL10068584 0.93 SMN1; SMN2 (0.38) ADRB1ADRB3MEN1MAPTKMT2A
SCHEMBL10069327 0.91 HTT (0.40) ADRB2ADRB1ADRB3MEN1MAPT
SCHEMBL10068808 0.89 HTT (0.43) ADRB2ADRB1ADRB3MEN1MAPT
SCHEMBL10068722 0.88 HTT (0.40) ADRB2ADRB1ADRB3MEN1MAPT
SCHEMBL10068802 0.87 KLKB1 (0.41) ADRB2ADRB1ADRB3MEN1MAPT
SCHEMBL10068545 0.86 ADRB2 (0.37) ADRB2ADRB1ADRB3MEN1MAPT
SCHEMBL10068771 0.86 FAAH (0.43) ADRB1ADRB3MEN1MAPTKMT2A
SCHEMBL10068578 0.86 HTT (0.45) ADRB2ADRB1ADRB3MEN1MAPT
SCHEMBL10068953 0.86 KLKB1 (0.40) ADRB2ADRB1ADRB3MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019428-A1 BENZOHYDROL DERIVATIVES, A PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed